Literature DB >> 22391552

The composition of the culture medium influences the β-1,3-glucan metabolism of Aspergillus fumigatus and the antifungal activity of inhibitors of β-1,3-glucan synthesis.

Cécile Clavaud1, Anne Beauvais, Lise Barbin, Hélène Munier-Lehmann, Jean-Paul Latgé.   

Abstract

In vitro testing of Aspergillus fumigatus susceptibility to echinocandins has always been a challenge. Using a simple and quick colorimetric method to analyze the activity of inhibitors of β-1,3-glucan synthesis, we found that the composition of the culture medium significantly influences glucan synthesis and consequently the antifungal properties of inhibitors of β-1,3-glucan synthesis when they are tested alone or in combination with chitin synthase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391552      PMCID: PMC3370737          DOI: 10.1128/AAC.05661-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus.

Authors:  Eleusa Maria F Rocha; Guillermo Garcia-Effron; Steven Park; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

2.  Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.

Authors:  Charalampos Antachopoulos; Joseph Meletiadis; Tin Sein; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

3.  Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.

Authors:  E Chryssanthou; M Cuenca-Estrella
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

4.  In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

5.  Two alpha(1-3) glucan synthases with different functions in Aspergillus fumigatus.

Authors:  A Beauvais; D Maubon; S Park; W Morelle; M Tanguy; M Huerre; D S Perlin; J P Latgé
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

6.  Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.

Authors:  M B Kurtz; I B Heath; J Marrinan; S Dreikorn; J Onishi; C Douglas
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

7.  Characterization of the 1,3-beta-glucan synthase of Aspergillus fumigatus.

Authors:  A Beauvais; R Drake; K Ng; M Diaquin; J P Latgé
Journal:  J Gen Microbiol       Date:  1993-12

8.  A colorimetric and spectrophotometric method for in vitro susceptibility testing of Aspergillus species against caspofungin.

Authors:  D T A Te Dorsthorst; R B M Groot Zwaaftink; A J M M Rijs; J Meletiadis; P E Verweij
Journal:  Med Mycol       Date:  2007-06       Impact factor: 4.076

9.  The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro.

Authors:  J C Bowman; P Scott Hicks; M B Kurtz; H Rosen; D M Schmatz; P A Liberator; C M Douglas
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

10.  Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.

Authors:  Charalampos Antachopoulos; Joseph Meletiadis; Tin Sein; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

View more
  24 in total

1.  α1,3 glucans are dispensable in Aspergillus fumigatus.

Authors:  Christine Henry; Jean-Paul Latgé; Anne Beauvais
Journal:  Eukaryot Cell       Date:  2011-11-04

2.  Chitin synthases with a myosin motor-like domain control the resistance of Aspergillus fumigatus to echinocandins.

Authors:  Cristina Jiménez-Ortigosa; Vishukumar Aimanianda; Laetitia Muszkieta; Isabelle Mouyna; David Alsteens; Stéphane Pire; Remi Beau; Sven Krappmann; Anne Beauvais; Yves F Dufrêne; César Roncero; Jean-Paul Latgé
Journal:  Antimicrob Agents Chemother       Date:  2012-09-10       Impact factor: 5.191

3.  Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals.

Authors:  Russell E Lewis; Guangling Liao; Katherine Young; Cameron Douglas; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

4.  The volatome of Aspergillus fumigatus.

Authors:  C Heddergott; A M Calvo; J P Latgé
Journal:  Eukaryot Cell       Date:  2014-06-06

5.  Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.

Authors:  Antigoni Elefanti; Johan W Mouton; Katerina Krompa; Rafal Al-Saigh; Paul E Verweij; Loukia Zerva; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

6.  Fungal cell wall dynamics and infection site microenvironments: signal integration and infection outcome.

Authors:  Kelly M Shepardson; Robert A Cramer
Journal:  Curr Opin Microbiol       Date:  2013-04-15       Impact factor: 7.934

Review 7.  Aspergillus cell wall and biofilm.

Authors:  Anne Beauvais; Thierry Fontaine; Vishukumar Aimanianda; Jean-Paul Latgé
Journal:  Mycopathologia       Date:  2014-06-20       Impact factor: 2.574

Review 8.  Overview of carbon and nitrogen catabolite metabolism in the virulence of human pathogenic fungi.

Authors:  Laure Nicolas Annick Ries; Sarah Beattie; Robert A Cramer; Gustavo H Goldman
Journal:  Mol Microbiol       Date:  2017-12-29       Impact factor: 3.501

9.  The Toxicity of a Novel Antifungal Compound Is Modulated by Endoplasmic Reticulum-Associated Protein Degradation Components.

Authors:  Shriya Raj; Karthik Krishnan; David S Askew; Olivier Helynck; Peggy Suzanne; Aurélien Lesnard; Sylvain Rault; Ute Zeidler; Christophe d'Enfert; Jean-Paul Latgé; Hélène Munier-Lehmann; Cosmin Saveanu
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

10.  A Novel Polyaminocarboxylate Compound To Treat Murine Pulmonary Aspergillosis by Interfering with Zinc Metabolism.

Authors:  Paris Laskaris; Rocío Vicentefranqueira; Olivier Helynck; Grégory Jouvion; José Antonio Calera; Laurence du Merle; Franck Suzenet; Frédéric Buron; Rodolphe Alves de Sousa; Daniel Mansuy; Jean-Marc Cavaillon; Jean-Paul Latgé; Hélène Munier-Lehmann; Oumaima Ibrahim-Granet
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.